Individual Study / APACE

Advantageous Predictors of Acute Coronary Syndromes Evaluation

Advantageous Predictors of Acute Coronary Syndromes Evaluation

APACE logo
Initiatives -
To test if the use of meticulous patient history, digital and analogue ECG parameter and novel biomarkers (including novel, sensitive and high-sensitive cardiac troponin I and T, Copeptin, myeloperoxydase, Endothelin) can provide a faster detection or exclusion of acute myocardial infarction in patients presenting with acute chest pain to the emergency department.
Start Year
2006
Funding
University Hospital, Basel, Switzerland
Visit APACE

Members

Download
Investigators Contacts
  • Dr. Christian Müller
    University Hospital-Basel

Design

Study design
Patients' cohort
Follow Up
. All patients will be contacted by telephone at 6, 12, 24 and 60 months to determine functional status, major adverse cardiac events (death, myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention), and the results of cardiac examination (stress test, coronary angiography) if performed.

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
8,000
Number of participants with biosamples
Supplementary Information
Over 18 years old

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

On the study website : http://www.dyspnea.ch/apace.htm